Skip to content

Clinical trials

Completed Phase 2 Neutropenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 2 Status: Completed Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20035
20043
20051
20063
20073
20082
20101
20113
20123
20134
20142
20152
20161
20172
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
National Heart, Lung, and Blood Institute (NHLBI)6
Alliance for Clinical Trials in Oncology2
EVIVE Biotechnology2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
AviGenics1
BioLab 612 LLC1
Biocad1
Cellerant Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia48
Breast Neoplasms10
Thrombocytopenia10
Leukemia8
Anemia6
Anemia, Aplastic4
Autoimmune Diseases4
Fever4
Infections4
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.